RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Marketable securities, current

ABBOTT LABORATORIESABT

Market cap
$223B
P/E ratio
SummaryFinancials
Period EndMarketable securities, current (Million USD)YoY (%)
Dec 31, 2024351-8.36%
Dec 31, 2023383+32.99%
Dec 31, 2022288-36.00%
Dec 31, 2021450+45.16%
Dec 31, 2020310+10.71%
Dec 31, 2019280+15.70%
Dec 31, 2018242+19.21%
Dec 31, 2017203+30.97%
Dec 31, 2016155-86.21%
Dec 31, 20151,124+183.12%
Dec 31, 2014397-91.41%
Dec 31, 20134,623+5.74%
Dec 31, 20124,372+240.36%
Dec 31, 20111,285-28.76%
Dec 31, 20101,803

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)